Up a level |
(2019) Immunogenicity Evaluation of Recombinant Edible Vaccine Candidate Containing HER2-MUC1 against Breast Cancer. Iranian Journal of Allergy Asthma and Immunology. pp. 511-522. ISSN 1735-1502
(2018) In silico analysis of chimeric subunit vaccine containing HER-2-MUC1 against breast cancer. Indian Journal of Biotechnology. pp. 224-233. ISSN 0972-5849